Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ANABANAB
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ANAPTYSBIO INC

BANK OF AMERICA CORP /DE/ holds 417,812 shares of ANAB (ANAPTYSBIO INC), worth $28.2M as of 2026-Q2. The position was decreased (-16.6% shares). ANAB represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$28.2M

Current Shares

417,812

Total Value Change

+$28M

Total Shares Change

+399,863

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
417,812
-16.6%
$28.2M0.0%$67.50
0
2026-Q1
Increased
501,086
+283.2%
$27.8M0.0%$52.83
46
2025-Q4
Increased
130,767
+2.8%
$6.3M0.0%$48.23
28
2025-Q3
Decreased
127,241
-88.2%
$3.9M0.0%$23.27
0
2025-Q2
Decreased
1.1M
-5.9%
$23.9M0.0%$22.47
0
2025-Q1
Increased
1.1M
+6273.4%
$21.3M0.0%$18.95
46
2024-Q4
New
17,949
-
$237,6450.0%$13.22
35

Other major holders of ANAB: ADAGE CAPITAL PARTNERS GP, L.L.C., BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used